MURAKAMI, M., ZHAO, S., ZHAO, Y., YU, W., FATEMA, C. N., NISHIJIMA, K., . . . KUGE, Y. (2013). Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model. D.A. Spandidos.
Citação norma ChicagoMURAKAMI, MASAHIRO, et al. Increased Intratumoral Fluorothymidine Uptake Levels Following Multikinase Inhibitor Sorafenib Treatment in a Human Renal Cell Carcinoma Xenograft Model. D.A. Spandidos, 2013.
MLA citiranjeMURAKAMI, MASAHIRO, et al. Increased Intratumoral Fluorothymidine Uptake Levels Following Multikinase Inhibitor Sorafenib Treatment in a Human Renal Cell Carcinoma Xenograft Model. D.A. Spandidos, 2013.
Opozorilo: Ti citati niso vedno 100% točni.